Conmed (CNMD) Profit After Tax (2010 - 2026)

Conmed's Profit After Tax history runs 17 years deep, the most recent figure standing at $15.4 million for Q1 2026.

• Quarterly Profit After Tax rose 105.79% year-over-year to $15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.8 million (down 42.6% YoY) and the FY2025 annual result came in at $59.6 million, down 51.82% from the prior year.
• Profit After Tax was $15.4 million for Q1 2026 at Conmed, down from $19.7 million in the prior quarter.
• Across five years, Profit After Tax topped out at $48.7 million in Q3 2024 and bottomed at -$172.6 million in Q2 2022.
• A 5-year average of $10.4 million and a median of $19.7 million in 2025 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2022 — Profit After Tax plunged 1072.98% — and 2024, when it soared 327.65%.
• Conmed's Profit After Tax stood at $28.9 million in 2022, then grew by 1.08% to $29.2 million in 2023, then gained by 1.52% to $29.6 million in 2024, then plunged by 33.56% to $19.7 million in 2025, then slipped by 21.55% to $15.4 million in 2026.
• Business Quant data shows CNMD's Profit After Tax at $15.4 million in Q1 2026, $19.7 million in Q4 2025, and $2.9 million in Q3 2025.